Can Fite Biopharma Ltd
General ticker "CANF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.1B
Can Fite Biopharma Ltd follows the US Stock Market performance with the rate: 7.9%.
Estimated limits based on current volatility of 2.3%: low 1.41$, high 1.49$
Factors to consider:
- Earnings expected soon, date: 2024-12-26 bmo
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.39$, 3.87$]
- 2024-12-30 to 2025-12-30 estimated range: [1.29$, 3.59$]
Short-term CANF quotes
Long-term CANF plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $0.74MM |
| Operating Expenses | $8.94MM |
| Operating Income | $-8.20MM |
| Non-Operating Income | $0.56MM |
| Interest Expense | $0.01MM |
| R&D Expense | $5.98MM |
| Income(Loss) | $-7.63MM |
| Profit(Loss) | $-7.63MM |
| Stockholders Equity | $6.24MM |
| Assets | $9.99MM |
| Operating Cash Flow | $-8.44MM |
| Capital expenditure | $0.00MM |
| Investing Cash Flow | $0.50MM |
| Financing Cash Flow | $9.14MM |
| Earnings Per Share* | $-1.79 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.